Noom Med vs NowPatient
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Noom Med
Best for psychology + medication comboStarting at $99/mo
NowPatient
Best for Brand-name GLP-1 access without a compounded routeStarting at $1069/mo
Side-by-Side Comparison
| Feature | Noom Med | NowPatient |
|---|---|---|
| Overall Score | ✓8.6/10 | 6.8/10 |
| Starting Price | ✓$99/mo | $1069/mo |
| Editorial Rating | ✓4.3 ★ /5 | 3.4 ★ /5 |
| Features | ✓3 features | 2 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | — |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Noom Med
Pros
- ✓Combines GLP-1 medication with CBT behavior change
- ✓Dedicated dietitian included in every plan
- ✓Highest support score in fitness app category
- ✓Integrated care team for medication and coaching
- ✓Noom's proven behavioral curriculum
Cons
- ✗Available in only 40 states — excludes AK, HI, ID, MT, NM, SD, VT, WV, WY, ND
- ✗More expensive than app-only alternatives
- ✗Requires commitment to both medication and coaching program
NowPatient
Pros
- ✓Free telehealth consultation — patients only pay the medication cost
- ✓Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
- ✓One of the few telehealth platforms offering Wegovy in both injection and oral pill form
- ✓No compounded options — every drug is FDA-approved brand
Cons
- ✗Cash-pay pricing tracks full brand list price (~$1,000-$1,350/mo)
- ✗Does not offer compounded semaglutide or tirzepatide (generally the cheaper route)
- ✗State availability not disclosed publicly — determined during intake
- ✗Phone: 1-866-967-1977, HQ Austin TX
- ✗Does NOT offer Foundayo (orforglipron)
Our Verdict
Noom Med edges out NowPatient with a higher overall score of 8.6/10 and is particularly strong for psychology + medication combo. NowPatient remains a solid alternative, especially if you're looking for Brand-name GLP-1 access without a compounded route.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.